PATENT CLAIM ANALYSIS

Application Number: 16199875
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "086000"]

Abstract:
Methods for inhibiting a ROS1 kinase with compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein ring A, ring B, W, m, D, R 2 , R 2a , R 3 , R 3a , and Z are as defined herein. The compounds and methods provided herein are useful in the treatment of cancer (e.g., ROS1-associated cancers as defined herein).

Claim (Index 4):
The method of  claim 1 , wherein the compound is (6R)-9-fluoro-13-oxa-2,11,16,20,21,24-hexaazapentacyclo[16.5.2.02,6.07,12.021,25]pentacosa-1(24),7, 9,11,18(25), 19,22-heptaen-17-one, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 98.0
- Lexical Diversity: 1.4898
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15401839', '15632187', '15401952', '14575663', '13698922']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8518004075534596
- 35 USC 102 Novelty (BERT): 0.6781795823547614
- Combined Prediction Score: 0.8344383250335898
- Mean Citation Score: 545.0916319999999
- Max Citation Score: 557.26263
- Similarity Product: 540.7565819113559

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test